You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 22, 2025

Drug Price Trends for NAFTIFINE HCL


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for NAFTIFINE HCL

Average Pharmacy Cost for NAFTIFINE HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NAFTIFINE HCL 2% CREAM 70700-0161-17 2.35196 GM 2025-03-19
NAFTIFINE HCL 2% CREAM 51672-1368-03 2.35196 GM 2025-03-19
NAFTIFINE HCL 2% CREAM 51672-1368-06 2.27135 GM 2025-03-19
NAFTIFINE HCL 2% CREAM 70700-0161-18 2.27135 GM 2025-03-19
NAFTIFINE HCL 1% CREAM 51672-1362-03 4.66364 GM 2025-03-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NAFTIFINE HCL

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
NAFTIN 2% GEL Sebela Pharmaceuticals, Inc. DBA Sebela Pharmaceuticals, Inc. 54766-0772-60 60GM 619.52 10.32533 GM 2024-04-01 - 2029-03-31 FSS
NAFTIN 1% GEL Sebela Pharmaceuticals, Inc. DBA Sebela Pharmaceuticals, Inc. 54766-0770-60 60GM 441.62 7.36033 GM 2024-04-01 - 2029-03-31 FSS
NAFTIN 1% GEL Sebela Pharmaceuticals, Inc. DBA Sebela Pharmaceuticals, Inc. 54766-0770-90 90GM 307.77 3.41967 GM 2024-04-01 - 2029-03-31 Big4
NAFTIN 1% GEL Sebela Pharmaceuticals, Inc. DBA Sebela Pharmaceuticals, Inc. 54766-0770-90 90GM 441.62 4.90689 GM 2024-04-01 - 2029-03-31 FSS
NAFTIN 2% GEL Sebela Pharmaceuticals, Inc. DBA Sebela Pharmaceuticals, Inc. 54766-0772-45 45GM 319.88 7.10844 GM 2024-04-01 - 2029-03-31 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Naftifine Hydrochloride Ointment Market Analysis and Price Projections

Overview of Naftifine Hydrochloride Ointment

Naftifine hydrochloride ointment is a topical antifungal medication commonly used to treat skin infections such as Tinea Corporis, Tinea Cruris, and Tinea Pedis. It belongs to the class of topical antifungals and is marketed under brand names like Naftin.

Market Size and Growth Projections

The global Naftifine Hydrochloride Ointment market has been experiencing significant growth driven by several key factors. As of 2023, the market was valued at USD 101 billion and is projected to reach USD 151 billion by 2031, indicating a substantial growth trajectory[3].

Compound Annual Growth Rate (CAGR)

The market is expected to grow at a compound annual growth rate (CAGR) of several percent from 2024 to 2031. This growth is fueled by increasing prevalence of skin diseases, growing awareness about skin care, and rising demand for antifungal ointments[1][3][4].

Market Segmentation

By Type

The market is segmented into two main types based on patient groups: adults and children. This segmentation helps in tailoring the product and marketing strategies to specific demographic needs[1][3][4].

By Application

The application segments include hospital pharmacy, retail pharmacy, and e-commerce. The rise of e-commerce has significantly impacted the distribution channels, making the product more accessible to a wider audience[1][3][4].

By Region

The global market is segmented into several regions:

  • North America (USA and Canada)
  • Europe (UK, Germany, France, and rest of Europe)
  • Asia Pacific (China, Japan, India, and rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and rest of Latin America)
  • Middle East & Africa (GCC and rest of the Middle East and Africa)[1][3][4].

Price Analysis

Current Pricing

The cost of naftifine hydrochloride ointment varies based on the formulation and quantity. For example:

  • A 2% topical cream can cost around $223 for a 45-gram supply[2].
  • A 1% topical gel can cost approximately $496 for a 40-gram supply[5].

Price Variability

Prices can vary significantly depending on the pharmacy, location, and availability. The use of discount cards, such as those offered by Drugs.com, can help reduce the cost by up to 80%[2][5].

Factors Influencing Market Growth

Increasing Prevalence of Skin Diseases

The rising incidence of skin infections is a major driver of the market. As more people seek treatment for these conditions, the demand for effective antifungal ointments like naftifine hydrochloride increases[1][3][4].

Growing Awareness About Skin Care

Enhanced awareness about skin health and the importance of timely treatment for skin infections have contributed to the market's growth. Consumers are increasingly seeking out effective and reliable treatments, driving demand for naftifine hydrochloride ointment[1][3][4].

High Capital Requirements

Entry into the naftifine hydrochloride ointment market requires substantial initial investment in manufacturing facilities, distribution networks, and marketing. This high capital requirement acts as a barrier for new entrants, allowing existing players to maintain their market share[3].

Regulatory Hurdles

Compliance with industry regulations and standards adds complexity and cost to market entry. Smaller firms or startups often find it challenging to navigate these regulatory requirements effectively[3].

Competitive Landscape

The market is dominated by several key players, including:

  • Merz Dermatology
  • Parchem Fine and Specialty Chemicals
  • LGM Pharma
  • Sebela Pharmaceuticals
  • Erregierre
  • Simagchem Corporation
  • Taro Pharmaceutical Industries
  • Renaissance Pharma
  • Shanghai Yisa Biotechnology
  • Shaanxi TOP Pharm Chemical[1].

These companies benefit from economies of scale, enabling them to lower production costs and offer competitive pricing, which poses a significant barrier for new entrants[3].

Regional Analysis

North America

North America, particularly the USA and Canada, is a significant market due to high healthcare spending and a well-developed pharmaceutical infrastructure[1][3][4].

Europe

Europe, with countries like Germany, France, and the UK, also represents a substantial market. The region's strong healthcare system and high demand for antifungal treatments contribute to its importance[1][3][4].

Asia Pacific

The Asia Pacific region, including countries like China, Japan, and India, is expected to see rapid growth due to increasing healthcare awareness and a large population base[1][3][4].

Latin America and Middle East & Africa

These regions are also growing, driven by improving healthcare infrastructure and increasing demand for antifungal treatments[1][3][4].

Key Takeaways

  • The global Naftifine Hydrochloride Ointment market is projected to grow significantly, reaching USD 151 billion by 2031.
  • The market is driven by increasing prevalence of skin diseases, growing awareness about skin care, and rising demand for antifungal ointments.
  • High capital requirements and regulatory hurdles pose significant barriers to new entrants.
  • The market is segmented by type (adults and children), application (hospital pharmacy, retail pharmacy, and e-commerce), and region.
  • Key players dominate the market due to economies of scale and competitive pricing.

FAQs

What is naftifine hydrochloride ointment used for?

Naftifine hydrochloride ointment is used to treat skin infections such as Tinea Corporis, Tinea Cruris, and Tinea Pedis.

How much does naftifine hydrochloride ointment cost?

The cost varies depending on the formulation and quantity, but a 2% topical cream can cost around $223 for a 45-gram supply, and a 1% topical gel can cost approximately $496 for a 40-gram supply.

What are the main drivers of the naftifine hydrochloride ointment market?

The main drivers include the increasing prevalence of skin diseases, growing awareness about skin care, and rising demand for antifungal ointments.

Who are the key players in the naftifine hydrochloride ointment market?

Key players include Merz Dermatology, Parchem Fine and Specialty Chemicals, LGM Pharma, Sebela Pharmaceuticals, and others.

What are the regulatory challenges in the naftifine hydrochloride ointment market?

Compliance with industry regulations and standards adds complexity and cost to market entry, posing a significant challenge for new entrants.

Sources

  1. Industry Growth Insights: Naftifine Hydrochloride Ointment Market Report | Global Forecast To...
  2. Drugs.com: Naftifine topical Prices, Coupons, Copay Cards & Patient Assistance
  3. OpenPR: Naftifine Hydrochloride Ointment Market Size, Trends Analysis
  4. Cognitive Market Research: Naftifine Hydrochloride Ointment Market Report 2024 (Global Edition)
  5. Drugs.com: Naftin Prices, Coupons, Copay Cards & Patient Assistance

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.